TriSalus Life Sciences Inc. Warrant (TLSIW) Live Share Price, Invest From India

TriSalus Life Sciences Inc. Warrant Stock Performance

as on June 17, 2026 at 2:16 pm IST

$0.65
Day's Price Range
$0.65
$0.65
52 Week's Low
52 Week's High
52-Week Price Range
$0.65
100.00%
Downside
-100.00%
Upside

TriSalus Life Sciences Inc. Warrant share price movements today

Previous Close: $0.64
Open: $0.65
Volume: 84.4K
Day's Low - High: $0.65 - $0.65

TriSalus Life Sciences Inc. Warrant Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

TriSalus Life Sciences Inc. Warrant Stock Fundamentals & Key Indicators

Check TriSalus Life Sciences Inc. Warrant market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

TriSalus Life Sciences Inc. Warrant stock Key Stats

Compare market cap, revenue, PE, and other key metrics of TriSalus Life Sciences Inc. Warrant with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
TriSalus Life Sciences Inc. Warrant	NA	$-	NA	NA	-60.85%	NA

TriSalus Life Sciences Inc. Warrant Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	5	6	7	7	8	9	11	11	13	8
Gross Profit	5	5	6	6	7	7	9	9	11	7
Operating Income	-14	-11	-8	-8	-7	-7	-7	-9	-3	-8
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	0	0	0	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-35	-13	-4	-2	-10	-10	-8	-10	-9	1
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-35	-13	-4	-2	-10	-10	-8	-10	-9	1
Net Profit Margin	-620.68%	-204.52%	-58.83%	-32.64%	-122.36%	-113.18%	-73.91%	-93.47%	-73.86%	17.29%

TriSalus Life Sciences Inc. Warrant Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	8	12	18	29	45
Gross Profit	7	10	15	25	38
Operating Income	-24	-36	-54	-36	-26
EBITDA	-26	-46	-	-	-
Interest Expense	1	0	0	3	5
Depreciation	0	0	0	0	0
Income Before Tax	-28	-47	-59	-30	-39
Income Tax Expense	-	-	-	-	-
Net Income	-28	-47	-59	-30	-39
Net Profit Margin	-343.35%	-380.60%	-320.69%	-102.09%	-86.88%

TriSalus Life Sciences Inc. Warrant Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-14	-5	-3	-10	-11	-9	-41	-9	1
Operating Cash Flow	-10	-13	-10	-5	-4	-7	-3	-2	-6
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	3	25	5	2	9	20	0	0	42
Change in Cash	-7	12	-5	-2	4	13	-3	-2	35

TriSalus Life Sciences Inc. Warrant Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-47	-63	-33	-39
Operating Cash Flow	-32	-50	-40	-18
Investing Cash Flow	-	-	-	-
Financing Cash Flow	13	54	37	30
Change in Cash	-20	2	-3	11

About TriSalus Life Sciences Inc. Warrant

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado.

Organisation	TriSalus Life Sciences Inc. Warrant
Headquarters	6272 West 91st Avenue, Westminster, CO, United States, 80031
Industry	Health Care
CEO	Ms. Mary T. Szela B.S.N., M.B.A.
E-voting on shares	Click here to vote

Key Management of TriSalus Life Sciences Inc. Warrant

Name	Title
Ms. Mary T. Szela B.S.N., M.B.A.	CEO, President & Director
Mr. David B. Patience	Chief Financial Officer
Dr. Richard B. Marshak M.B.A., VMD	Chief Commercial Officer
Andrea Marasso	Vice President of Marketing
Ms. Jennifer L. Stevens J.D.	Chief Regulatory, Quality and Therapeutics Officer
Dr. Bryan F. Cox Ph.D.	Chief of Research
Dr. Richard Marshall M.D.	Medical Director

FAQs

What is TriSalus Life Sciences Inc. Warrant share price today?

TriSalus Life Sciences Inc. Warrant share price today is $0.65 as on June 17, 2026 at 8:46 am IST at the close of the market. TriSalus Life Sciences Inc. Warrant share today touched a day high of $0.65 and a low of $0.65.

What is the 52 week high and 52 week low for TriSalus Life Sciences Inc. Warrant share?

TriSalus Life Sciences Inc. Warrant share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. TriSalus Life Sciences Inc. Warrant stock price today i.e. June 17, 2026 at 8:46 am IST is closed at $0.65,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in TriSalus Life Sciences Inc. Warrant Stock (TLSIW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for TriSalus Life Sciences Inc. Warrant on INDmoney app. Click on Buy button. You can invest as low as $1.5 in TriSalus Life Sciences Inc. Warrant Shares that will get you 2.3077 shares as per TriSalus Life Sciences Inc. Warrant share price of $0.65 per share as on June 17, 2026 at 8:46 am IST.

What is the minimum amount required to buy TriSalus Life Sciences Inc. Warrant Stock (TLSIW) from India?

Indian investors can start investing in TriSalus Life Sciences Inc. Warrant (TLSIW) shares with as little as ₹94.5 or $1 (as of June 17, 2026 at 6:46 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in TriSalus Life Sciences Inc. Warrant stock (as per the Rupee-Dollar exchange rate as on June 17, 2026 at 6:46 pm IST). Based on TriSalus Life Sciences Inc. Warrant share’s latest price of $0.65 as on June 17, 2026 at 8:46 am IST, you will get 15.3846 shares of TriSalus Life Sciences Inc. Warrant. Learn more about fractional shares .